MedTrace Logo

Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room

NCT01091337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2010-03-24

No results posted yet for this study

Summary

To compare the efficacy and safety of inhaled procaterol (Meptin Air) versus inhaled salbutamol as metered dose inhaler (MDI) reliever of acute exacerbation of asthma not in imminent respiratory failure.

Conditions

Interventions

DRUG

Procaterol

Procaterol(Meptin Air) MDI, 20 ug or 2 puffs every 20 minutes \+ Hydrocortisone, 100 mg IV shall be given immediately at start of treatment

DRUG

Salbutamol

Salbutamol(Ventolin Inhaler) MDI, 40 ug or 4 puffs every 20 minutes + Hydrocortisone, 100 mg IV shall be given immediately at start of treatment

Sponsors & Collaborators

  • Otsuka Pharmaceutical, Inc., Philippines

    lead INDUSTRY

Principal Investigators

  • Camilo Roa, MD · Philippine General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01091337 on ClinicalTrials.gov